- Home
- AIZ vs MDGL Comparison
AIZ vs MDGL Comparison
Compare AIZ & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIZ
- MDGL
- Stock Information
- Founded
- AIZ 1892
- MDGL 2011
- Country
- AIZ United States
- MDGL United States
- Employees
- AIZ N/A
- MDGL N/A
- Industry
- AIZ Property-Casualty Insurers
- MDGL Biotechnology: Pharmaceutical Preparations
- Sector
- AIZ Finance
- MDGL Health Care
- Exchange
- AIZ Nasdaq
- MDGL Nasdaq
- Market Cap
- AIZ 11.4B
- MDGL 9.6B
- IPO Year
- AIZ N/A
- MDGL N/A
- Fundamental
- Price
- AIZ $227.63
- MDGL $553.33
- Analyst Decision
- AIZ Buy
- MDGL Strong Buy
- Analyst Count
- AIZ 6
- MDGL 13
- Target Price
- AIZ $249.17
- MDGL $543.33
- AVG Volume (30 Days)
- AIZ 312.0K
- MDGL 448.5K
- Earning Date
- AIZ 11-04-2025
- MDGL 11-04-2025
- Dividend Yield
- AIZ 1.56%
- MDGL N/A
- EPS Growth
- AIZ 17.21
- MDGL N/A
- EPS
- AIZ 16.41
- MDGL N/A
- Revenue
- AIZ $12,568,700,000.00
- MDGL $740,640,000.00
- Revenue This Year
- AIZ $7.85
- MDGL $395.75
- Revenue Next Year
- AIZ $4.82
- MDGL $65.73
- P/E Ratio
- AIZ $13.82
- MDGL N/A
- Revenue Growth
- AIZ 6.92
- MDGL 864.21
- 52 Week Low
- AIZ $174.97
- MDGL $265.00
- 52 Week High
- AIZ $232.02
- MDGL $577.90
- Technical
- Relative Strength Index (RSI)
- AIZ 63.19
- MDGL 69.17
- Support Level
- AIZ $223.22
- MDGL $505.00
- Resistance Level
- AIZ $230.00
- MDGL $571.16
- Average True Range (ATR)
- AIZ 4.72
- MDGL 31.37
- MACD
- AIZ 0.46
- MDGL 5.51
- Stochastic Oscillator
- AIZ 76.08
- MDGL 84.89
About AIZ Assurant Inc.
Assurant Inc is a protection company that partners with the brands to safeguard and service connected devices, homes and automobiles. It operate in North America, Latin America, Europe and Asia Pacific through two operating segments: Global Lifestyle and Global Housing. Global Lifestyle: includes mobile device solutions (including extended service contracts, insurance policies and related services), extended service contracts and related services for consumer electronics and appliances, and financial services and other insurance products. Global Housing: includes lender-placed homeowners, manufactured housing and flood insurance, as well as voluntary manufactured housing, condominium and homeowners insurance. Key revenue is generated from Global Lifestyle segment.
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.